The Irish Times

Tesla bull Cathie Wood says it isn’t just Elon Musk’s politics that are causing Tesla’s ‘demand hit.’ It’s also a bad economy

DW (English)

Retailers are getting antsy over consumer environment, tariffs

Nacion.com

China’s BYD overtakes Tesla as the world’s top EV seller – Is this the end of Tesla’s reign, or can their refreshed Model Y fight back? What’s behind the shift and what it means for the future of electric cars?

Biztoc.com

FDIC Clears Path for Bank Crypto Activities Without Prior Approval

Cnbeta.com.tw

SpearUAV Announces Completion of a Significant Funding Round Led by Deep Insight Venture Fund

Biztoc.com

Citi Wealth chief investment officer says she would not put any more money in stocks right now

TheWrap

‘Spider-Man,’ ‘Harry Potter’ producers hired for new 007 film

Olhardigital.com.br

BlackRock Unveils Bitcoin ETP in Europe: What This Means for Investors

Memeorandum.com

Now Is 'Really Good Time' to Buy Bitcoin, Says Trillion Dollar Investment Manager

The Irish Times

Musk’s xAI buys social media platform X for $45 billion

DW (English)

Aranceles a los automóviles: se acerca el próximo golpe de Trump

Nacion.com

Bolsonaro será juzgado en Brasil por intento de golpe de Estado

Biztoc.com

US stocks slide in 1st trading since Trump's auto tariffs announced

Cnbeta.com.tw

马斯克称他的人工智能初创公司xAI收购了X平台 对后者估值为330亿美元

Biztoc.com

Elon Musk Says AI Has Purchased X, Formerly Known As Twitter, For $33 Billion

TheWrap

X Acquired by Elon Musk’s AI Company for $45 Billion

Olhardigital.com.br

Guerra tech: governo Trump impõe novas restrições à China

Memeorandum.com

Trump imposes sweeping auto tariffs in latest trade crackdown (Ben Berkowitz/Axios)

Biztoc.com

Elon Musk’s artificial intelligence group buys X for $45bn

Common Dreams

'Abhorrent. Evil. Indefensible.' Trump Cutting Vaccine Alliance Funds Could Kill 1.2 Million Children Worldwide

GlobeNewswire

The Global Market for Paclitaxel Injections Presents an $11.17 Billion Revenue Opportunity by 2029 - Analysis of Key Players Pfizer, BMS, Fresenius Kabi Oncology, Abbott Labs, and Viatris Among Others